Altai Protocol Library New Drug: Mezigdomide with Carfilzomib – Dexamethasone for Multiple Myeloma U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Indication: Adjuvant Ensartinib for Resected ALK-Positive NSCLC U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Neoadjuvant Durvalumab with Dose-Dense MVAC for Bladder Cancer U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Reference: Oral Decitabine and Venetoclax for Newly Diagnosed AML U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Drug: Aumolertinib for EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Perioperative Serplulimab with Chemotherapy for PD-L1 Positive Gastric Cancer U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Protocol: Sacituzumab Tirumotecan with Pembrolizumab for PD-L1 Positive Advanced NSCLC U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Reference: Perioperative Pembrolizumab for MSI-H/dMMR Colorectal Cancer U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Reference: Ivonescimab with Chemotherapy for Advanced Squamous NSCLC U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Indication: Duvelisib for Peripheral T-Cell Lymphoma U. Darda Bayraktar, MD 2026-06-17
